Scholars Central

EditorialPublished 27 Apr 2023

Microbial Chemistry as a Structural Blueprint for Rational Drug Design

Authors: Pavel I. Novák

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Drug design aims to create chemical entities capable of selectively interacting with biological targets to produce therapeutic effects. Microbial chemistry has become an invaluable contributor to this process by providing structurally refined and biologically active molecules that inform rational drug design strategies. Microbial metabolites often exhibit optimized molecular features shaped by evolutionary pressures, making them highly suitable as templates for chemical modification. This article explores the role of microbial chemistry in drug design, emphasizing how microbial-derived structures guide molecular optimization, target specificity, and the development of next-generation therapeutics.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Current Chemical and Pharmaceutical Sciences.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Current Chemical and Pharmaceutical Sciences
  • SubjectPharmaceutical Sciences
  • SubjectChemistry
  • BylineArticles whose byline prints “Pavel I. Novák”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels